{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T22:41:34Z","timestamp":1784673694431,"version":"3.55.0"},"reference-count":35,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T00:00:00Z","timestamp":1723075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPM"],"abstract":"<jats:p>Background: This study evaluated the clinical outcomes of applying a 68 Gy EQD2(\u03b1\/\u03b2=3) dose constraint to the most exposed 2 cm3 area of the vagina in post-operative endometrial cancer patients treated with vaginal-cuff brachytherapy after external beam irradiation and the impact of vaginal dilator use on late vaginal complications. Material and methods: We analyzed 131 patients treated with vaginal-cuff brachytherapy after external beam irradiation. Group-1 (65 patients) received one fraction of 7 Gy, and Group-2 (66 patients) received one fraction of between 5.5 and 7.0 Gy after applying a 68 Gy EQD2(\u03b1\/\u03b2=3) dose constraint. Vaginal-cuff relapse, late toxicity, clinical target volume, vaginal dilator use, D90, and EQD2(\u03b1\/\u03b2=3) at 2 cm3 of the most exposed part of the clinical target volume were evaluated. Descriptive analysis, the chi-squared test, Student\u2019s t-test, and the Cox proportional and Kaplan\u2013Meier models were used for the statistical analysis. Results: With a median follow-up of 60 months, the vaginal-cuff relapse rate was 1\/131 (0.8%). Late vaginal complications appeared in 36\/65 (55.4%) Group-1 patients and 17\/66 (25.8%) Group-2 patients (p = 0.003). Multivariate analysis showed that belonging to Group-1 and vaginal dilator use of &lt;9 months were independent prognostic factors of late vaginal complications with hazard ratios of 1.99 (p = 0.021) and 3.07 (p = 0.010), respectively. Conclusions: A 68 Gy EQD2(\u03b1\/\u03b2=3) constraint at 2 cm3 of clinical target volume and vaginal dilator use of \u22659 months were independent prognostic factors, having protective effects on late vaginal complications.<\/jats:p>","DOI":"10.3390\/jpm14080838","type":"journal-article","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T15:04:24Z","timestamp":1723129464000},"page":"838","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Impact of Vaginal Dilator Use and 68 Gy EQD2(\u03b1\/\u03b2=3) Dose Constraint on Vaginal Complications in External Beam Irradiation Followed by Brachytherapy in Post-Operative Endometrial Cancer"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7970-876X","authenticated-orcid":false,"given":"Faegheh","family":"Noorian","sequence":"first","affiliation":[{"name":"Fonaments Cl\u00ednics Department, Universitat de Barcelona, 08036 Barcelona, Spain"},{"name":"Radiation Oncology Department, Hospital Clinic, Universitat de Barcelona, 08036 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Abellana","sequence":"additional","affiliation":[{"name":"Fonaments Cl\u00ednics Department, Universitat de Barcelona, 08036 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaowen","family":"Zhang","sequence":"additional","affiliation":[{"name":"Cancer Center, Henan Provincial People\u2019s Hospital, No.7 Weiwu Road, Zhengzhou 450003, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9867-481X","authenticated-orcid":false,"given":"Antonio","family":"Herreros","sequence":"additional","affiliation":[{"name":"Fonaments Cl\u00ednics Department, Universitat de Barcelona, 08036 Barcelona, Spain"},{"name":"Radiation Oncology Department, Hospital Clinic, Universitat de Barcelona, 08036 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3507-7051","authenticated-orcid":false,"given":"Valentina","family":"Lancellotta","sequence":"additional","affiliation":[{"name":"Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Policlinic Universitario Gemelli, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2308-0982","authenticated-orcid":false,"given":"Luca","family":"Tagliaferri","sequence":"additional","affiliation":[{"name":"Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Policlinic Universitario Gemelli, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0111-9540","authenticated-orcid":false,"given":"Sebasti\u00e0","family":"Sabater","sequence":"additional","affiliation":[{"name":"Radiation Oncology Department, Hospital General Universitario de Albacete, 02006 Albacete, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4700-9507","authenticated-orcid":false,"given":"Aureli","family":"Torne","sequence":"additional","affiliation":[{"name":"Gynaecological Cancer Unit, Hospital Clinic, Universitat de Barcelona, 08036 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Agusti-Camprubi","sequence":"additional","affiliation":[{"name":"Radiological Protection Department, Hospital Clinic, Universitat de Barcelona, 08036 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7832-334X","authenticated-orcid":false,"given":"Angeles","family":"Rovirosa","sequence":"additional","affiliation":[{"name":"Fonaments Cl\u00ednics Department, Universitat de Barcelona, 08036 Barcelona, Spain"},{"name":"Radiation Oncology Department, Hospital Clinic, Universitat de Barcelona, 08036 Barcelona, Spain"},{"name":"Gynaecological Cancer Unit, Hospital Clinic, Universitat de Barcelona, 08036 Barcelona, Spain"},{"name":"Institut d\u2019Investigaci\u00f3 Biom\u00e8dica Agust\u00ed Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,8,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/ijgo.13866","article-title":"Cancer of the corpus uteri: 2021 update","volume":"155","author":"Koskas","year":"2021","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.prro.2022.09.002","article-title":"Radiation Therapy for Endometrial Cancer: An American Society for Radiation Oncology Clinical Practice Guideline","volume":"13","author":"Harkenrider","year":"2023","journal-title":"Pract. Radiat. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","article-title":"ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma","volume":"31","author":"Concin","year":"2021","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Giustozzi, A., Salutari, V., Giudice, E., Musacchio, L., Ricci, C., Landolfo, C., Perri, M.T., Scambia, G., and Lorusso, D. (2021). Refining Adjuvant Therapy for Endometrial Cancer: New Standards and Perspectives. Biology, 10.","DOI":"10.3390\/biology10090845"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.ijrobp.2016.12.035","article-title":"Brachytherapy Improves Survival in Stage III Endometrial Cancer With Cervical Involvement","volume":"97","author":"Bingham","year":"2017","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Glatzer, M., Tanderup, K., Rovirosa, A., Fokdal, L., Ordeanu, C., Tagliaferri, L., Chargari, C., Strnad, V., Dimopoulos, J.A., and \u0160egedin, B. (2022). Role of Brachytherapy in the Postoperative Management of Endometrial Cancer: Decision-Making Analysis among Experienced European Radiation Oncologists. Cancers, 14.","DOI":"10.3390\/cancers14040906"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"221","DOI":"10.5114\/jcb.2021.105291","article-title":"Adjuvant vaginal cuff brachytherapy in surgically treated endometrial carcinoma patients\u2014In view of the recent evidence","volume":"13","author":"Serkies","year":"2021","journal-title":"J. Contemp. Brachytherapy"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1200\/JCO.18.01575","article-title":"Phase III Trial: Adjuvant Pelvic Radiation Therapy Versus Vaginal Brachytherapy Plus Paclitaxel\/Carboplatin in High-Intermediate and High-Risk Early Stage Endometrial Cancer","volume":"37","author":"Randall","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.brachy.2019.02.008","article-title":"Compendium of fractionation choices for gynecologic HDR brachytherapy-An American Brachytherapy Society Task Group Report","volume":"18","author":"Albuquerque","year":"2019","journal-title":"Brachytherapy"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.ejca.2011.11.014","article-title":"Five-year quality of life of endometrial cancer patients treated in the randomised Post Operative Radiation Therapy in Endometrial Cancer (PORTEC-2) trial and comparison with norm data","volume":"48","author":"Nout","year":"2012","journal-title":"Eur. J. Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2147\/IJWH.S106796","article-title":"Radiation-induced vaginal stenosis: Current perspectives","volume":"9","author":"Morris","year":"2017","journal-title":"Int. J. Womens Health"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jsxm.2020.12.013","article-title":"Diagnostic Methods for Vaginal Stenosis and Compliance to Vaginal Dilator Use: A Systematic Review","volume":"18","author":"Haddad","year":"2021","journal-title":"J. Sex. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s12094-021-02737-z","article-title":"Preliminary results of a vaginal constraint for reducing G2 late vaginal complications after postoperative brachytherapy in endometrial cancer: A prospective analysis","volume":"24","author":"Zhang","year":"2022","journal-title":"Clin. Transl. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1200\/JCO.2015.62.5459","article-title":"Postoperative radiation therapy for endometrial cancer: American society of clinical oncology clinical practice guideline endorsement of the American society for radiation oncology evidence-based guideline","volume":"33","author":"Meyer","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Varyt\u0117, G., and Bartkevi\u010dien\u0117, D. (2021). Pelvic Radiation Therapy Induced Vaginal Stenosis: A Review of Current Modalities and Recent Treatment Advances. Medicina, 57.","DOI":"10.3390\/medicina57040336"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.radonc.2005.11.014","article-title":"Recommendations from gynaecological (GYN) GEC ESTRO Working Group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy\u20143D dose volume parameters and aspects of 3D image-based anatomy, radiation physics","volume":"78","author":"Limbergen","year":"2006","journal-title":"Radiobiol. Radiother. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"40","DOI":"10.5114\/jcb.2018.74140","article-title":"Late G2 vagina toxicity in post-operative endometrial carcinoma is associated with a 68 Gy dose equivalent to 2 Gy per fraction (\u03b1\/\u03b2 = 3Gy) at 2 cm3 of vagina","volume":"10","author":"Aguilera","year":"2018","journal-title":"J. Contemp. Brachytherapy"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.rpor.2020.01.002","article-title":"Postoperative endometrial carcinoma treated with external beam irradiation plus vaginal-cuff brachytherapy. Is there a dose relationship with G2 vaginal complications?","volume":"25","author":"Zhang","year":"2020","journal-title":"Rep. Pract. Oncol. Radiother."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"109909","DOI":"10.1016\/j.radonc.2023.109909","article-title":"Are 7.5 Gy \u00d7 2 fractions more efficient than 6 Gy \u00d7 3 in exclusive postoperative endometrial cancer brachytherapy? A clinical and dosimetrical analysis","volume":"189","author":"Noorian","year":"2023","journal-title":"Radiother. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","article-title":"Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)","volume":"31","author":"Cox","year":"1995","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0360-3016(02)04578-9","article-title":"Evaluation of the LENT-SOMA scales for the prospective assessment of treatment morbidity in cervical carcinoma","volume":"56","author":"Routledge","year":"2003","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_22","first-page":"90","article-title":"Using the Common Terminology Criteria for Adverse Events (CTCAE\u2014Version 5.0) to Evaluate the Severity of Adverse Events of Anticancer Therapies","volume":"112","author":"Santana","year":"2021","journal-title":"Actas Dermosifiliogr."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1007\/s12094-023-03099-4","article-title":"Vaginal dilator use more than 9 months is a main prognostic factor for reducing G2-late vaginal complications in 3D-vaginal-cuff brachytherapy (interventional radiotherapy)?","volume":"25","author":"Zhang","year":"2023","journal-title":"Clin. Transl. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.radonc.2015.12.025","article-title":"Dose\u2013Effect relationship and risk factors for vaginal stenosis after definitive radio(chemo)therapy with image-guided brachytherapy for locally advanced cervical cancer in the EMBRACE study","volume":"118","author":"Kirchheiner","year":"2016","journal-title":"Radiother. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/0360-3016(80)90227-8","article-title":"Radiation tolerance of the vaginal mucosa","volume":"6","author":"Hintz","year":"1980","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.3802\/jgo.2017.28.e84","article-title":"Impact of vaginal cylinder diameter on outcomes following brachytherapy for early stage endometrial cancer","volume":"28","author":"Qian","year":"2017","journal-title":"J. Gynecol. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3870","DOI":"10.1002\/cncr.28849","article-title":"Complications of pelvic radiation in patients treated for gynecologic malignancies","volume":"120","author":"Viswanathan","year":"2014","journal-title":"Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.brachy.2015.03.001","article-title":"Predictors of vaginal stenosis after intravaginal high-dose-rate brachytherapy for endometrial carcinoma","volume":"14","author":"Park","year":"2015","journal-title":"Brachytherapy"},{"key":"ref_29","first-page":"484","article-title":"Determination of Prognostic Factors for Vaginal Mucosal Toxicity Associated with Intravaginal High-Dose Rate Brachytherapy in Patients with Endometrial Cancer","volume":"79","author":"Bahng","year":"2011","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/ijgc-00009577-200601000-00046","article-title":"Vaginal stenosis in patients treated with radiotherapy for carcinoma of the cervix","volume":"16","author":"Brand","year":"2006","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/1097-0142(197208)30:2<426::AID-CNCR2820300219>3.0.CO;2-M","article-title":"Vaginal stenosis following irradiation therapy for carcinoma of the cervix uteri","volume":"30","author":"Hartman","year":"1972","journal-title":"Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1007\/s00520-018-4441-5","article-title":"Extended duration of dilator use beyond 1 year may reduce vaginal stenosis after intravaginal high-dose-rate brachytherapy","volume":"27","author":"Stahl","year":"2019","journal-title":"Support. Care Cancer"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1097\/IGC.0000000000000253","article-title":"Sexual rehabilitation after pelvic radiotherapy and vaginal dilator use: Consensus using the Delphi method","volume":"24","author":"Bakker","year":"2014","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Matos, S.R.L., Lucas Rocha Cunha, M., Podgaec, S., Weltman, E., Yamazaki Centrone, A.F., and Cintra Nunes Mafra, A.C. (2019). Consensus for vaginal stenosis prevention in patients submitted to pelvic radiotherapy. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0221054"},{"key":"ref_35","first-page":"48","article-title":"The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies","volume":"9","author":"Tanderup","year":"2018","journal-title":"Clin. Transl. Radiat. Oncol."}],"container-title":["Journal of Personalized Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4426\/14\/8\/838\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:32:15Z","timestamp":1760110335000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4426\/14\/8\/838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,8]]},"references-count":35,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["jpm14080838"],"URL":"https:\/\/doi.org\/10.3390\/jpm14080838","relation":{},"ISSN":["2075-4426"],"issn-type":[{"value":"2075-4426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,8]]}}}